Sanofi

In News

FDA cites severe liver injury risk, unclear benefit behind Sanofi's MS drug rejection - Fierce Biotech

Fierce Biotech - Jan 06, 2026

Sanofi and Earendil Labs forge $2.56bn autoimmune deal - Pharmaceutical Technology

Pharmaceutical Technology - Jan 06, 2026

Sanofi’s MS Drug Tripped Up by Toxicities, Unclear Benefit, Rejection Letter Reveals - BioSpace

BioSpace - Jan 06, 2026

Rx Rundown: Insilico Medicine, Sanofi, Eli Lilly and more - Medical Marketing and Media

Medical Marketing and Media - Jan 09, 2026

Firm Advises InduPro on Strategic Investment, Research Collaboration with Sanofi - Wilson Sonsini

Wilson Sonsini - Jan 08, 2026

Is It Time To Reassess Sanofi (ENXTPA:SAN) After Recent Share Price Weakness - simplywall.st

simplywall.st - Jan 10, 2026

Is Sanofi (ENXTPA:SAN) Pricing Reflect Its Discounted Cash Flow Potential Today - Yahoo Finance

Yahoo Finance - Jan 07, 2026

Tolebrutinib Receives FDA CRL for Nonrelapsing Secondary Progressive Multiple Sclerosis - Pharmacy Times

Pharmacy Times - Jan 05, 2026

Sanofi calls rejection of potential MS blockbuster 'unexpected,' says it saw 'evolving' FDA perspectives - Endpoints News

Endpoints News - Jan 08, 2026

Enable Injections Announces $30 Million Investment from Sanofi to Accelerate Manufacturing Capabilities - GlobeNewswire

GlobeNewswire - Jan 06, 2026

Sanofi Fell 13% in a Year. Here’s Why It Could Be Shaping Up for a Comeback in 2026. - TIKR.com

TIKR.com - Jan 09, 2026

Sanofi pushes ahead on adult vaccines with $2.2 billion Dynavax deal - Reuters

Reuters - Dec 24, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment